Monroe Community Hospital is a chronic-care center in Rochester that is operated by Monroe County. They also have a Skilled Nursing Facility

There are 566 beds in Monroe Community Hospital.

During the past decade, Monroe Community Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monroe Community Hospital" #1 sponsor was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 4 trials, followed by "Genentech, Inc." with 2 trials sponsored, "OPKO Health, Inc." with 2 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Forest Laboratories" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monroe Community Hospital" #1 collaborator was "Pfizer" with 5 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Monroe Community Hospital" are "Alzheimer's Disease" (12 trials), "Alzheimer Disease" (3 trials), "Agitation" (1 trials), "Dementia" (1 trials) and "Mild to Severe Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Monroe Community Hospital" in a lesser frequency.

Most popular intervention types in "Monroe Community Hospital" are "Drug" (15 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo Control" (3 trials), "placebo" (3 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "bapineuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Monroe Community Hospital" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Monroe Community Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Monroe Community Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Monroe Community Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".